Gritstone bio Inc (NASDAQ:GRTS)
| 2.71 BATS BZX Real-Time Price As of 1:18pm ET |  -0.04 / -1.45%Today’s Change | 1.71 Today|||52-Week Range 14.42 | -78.93% Year-to-Date |
Latest GRTS News | Press Releases
No recent news for Gritstone bio Inc.
Today’s Trading
| Previous close | 2.75 |
| Today’s open | 2.71 |
| Day’s range | 2.67 - 2.80 |
| Volume | 28,512 |
| Average volume (3 months) | 1,329,313 |
| Market cap | $179.1M |
Data as of 1:18pm ET, 07/06/2022
Growth & Valuation
| Earnings growth (last year) | +65.84% |
| Earnings growth (this year) | -64.67% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +1,057.22% |
| P/E ratio | NM |
| Price/Sales | 21.72 |
| Price/Book | 0.79 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MGNXMacroGenics Inc | +0.05 | +1.52% |
| THTXTheratechnologies In... | -0.06 | -2.80% |
| OMEROmeros Corp | +0.50 | +16.13% |
| CMRXChimerix Inc | -0.10 | -4.27% |
Data as of 1:18pm ET, 07/06/2022
Financials
| Next reporting date | August 15, 2022 |
| EPS forecast (this quarter) | -$0.40 |
| Annual revenue (last year) | $46.7M |
| Annual profit (last year) | -$75.1M |
| Net profit margin | -160.72% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Emeryville, California |
Forecasts
